{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:49:06Z","timestamp":1794019746485,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Feline infectious peritonitis (FIP) is a lethal, immune-mediated disease caused by feline coronavirus (FCoV). FIP was considered untreatable; however, GS-441524, a nucleoside analog, has become a hopeful antiviral treatment. Despite its effectiveness, survival outcomes depend on several prognostic factors, especially the type of disease and clinical presentation. This research aimed to assess the effectiveness of GS-441524 in a large population of cats with FIP in Iran, examine survival rates, and identify crucial prognostic factors affecting treatment outcomes. Additionally, it evaluates alterations in clinical, laboratory, and imaging outcomes during treatment, proposing a secure treatment protocol for veterinarians utilizing GS-441524 for FIP. This retrospective study analyzed 629 cats diagnosed with or highly suspected of having FIP in Iran between December 2020 and March 2024. Diagnosis was based on clinical signs, laboratory findings, ultrasonographic features, and therapeutic responses. Cats received GS-441524 via subcutaneous injection and\/or oral administration for a minimum of 12\u00a0weeks. Dosages were adjusted according to the FIP form, and clinical, laboratory, and imaging data were collected before, during, and at the end of treatment with GS-441524. Dosages were further adjusted based on FIP form, weight gain, clinical improvement, and laboratory or imaging results. Statistical analyses comprised ANOVA, t-tests, chi-square tests, and non-parametric techniques to pinpoint important prognostic indicators and treatment effects. The survival rate reached 94.12%, with a relapse rate of 0.63%. Most reported type was Effusive forms accounted for 54.84% of the cats. Key prognostic factors associated with reduced survival included being male, over 6\u00a0years old, having neurological or mixed forms of FIP, and exhibiting fever, icterus, anemia, and thrombocytopenia (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Significant improvements were observed in parameters such as the A: G ratio, albumin, globulin, bilirubin levels, and changing in imaging findings. The study also assessed dosage modifications during treatment. The average starting dose for effusive forms was 6.9\u00a0mg\/kg, later increasing to 10.11\u00a0mg\/kg, while neurological and mixed forms initially required 9.65\u00a0mg\/kg, which was then raised to 12.7\u00a0mg\/kg. Treatment duration extended beyond 84\u00a0days for 17.32% of cats (109 cats) due to showing abnormalities. Imaging studies confirmed a gradual resolution of abdominal and pleural effusions, reduced lymph node size (both abdominal and mediastinal), decreased kidney size in cats of renomegaly, and regression of gallbladder edema. This research features the largest group of FIP-treated cats in Iran and ranks among the largest worldwide, showcasing impressive survival rates with GS-441524 treatment. Positive results rely on timely intervention, suitable dosage modifications, and extended treatment periods, particularly for cats showing neurological and ocular signs. Major risk factors affecting lower survival rates were fever, icterus, anemia, and low platelet count. These findings provide vital clinical insights for veterinarians, underscoring the need for customized treatment approaches and continued research to enhance FIP outcomes therapy and long-term care.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-30674-2","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T20:45:26Z","timestamp":1765226726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of risk factors, clinical data, treatment outcomes for cats with feline infectious peritonitis using GS-441524 (2020\u20132024)"],"prefix":"10.1038","volume":"16","author":[{"given":"Maneli","family":"Ansari Mood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"30674_CR1","first-page":"7","volume":"23","author":"N Pedersen","year":"1995","unstructured":"Pedersen, N. An overview of feline enteric coronavirus and infectious peritonitis virus infections. Feline Pract. 23, 7\u201320 (1995).","journal-title":"Feline Pract."},{"key":"30674_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/v15091847","author":"S Tasker","year":"2023","unstructured":"Tasker, S. et al. Feline infectious peritonitis: European advisory board on cat diseases guidelines. Viruses https:\/\/doi.org\/10.3390\/v15091847 (2023).","journal-title":"Viruses"},{"key":"30674_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005531","author":"Y Kim","year":"2016","unstructured":"Kim, Y. et al. Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1005531 (2016).","journal-title":"PLoS Pathog."},{"key":"30674_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X19825701","author":"NC Pedersen","year":"2019","unstructured":"Pedersen, N. C. et al. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J. Feline Med. Surg. https:\/\/doi.org\/10.1177\/1098612X19825701 (2019).","journal-title":"J. Feline Med. Surg."},{"key":"30674_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1015355","author":"Z Wang","year":"2022","unstructured":"Wang, Z., Yang, L. & Song, X. Q. Oral GS-441524 derivatives: Next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1015355 (2022).","journal-title":"Front. Immunol."},{"key":"30674_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29517-9","author":"SR Radoshitzky","year":"2023","unstructured":"Radoshitzky, S. R. et al. Expanded profiling of remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-023-29517-9 (2023).","journal-title":"Sci. Rep."},{"key":"30674_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2018.04.026","author":"BG Murphy","year":"2018","unstructured":"Murphy, B. G. et al. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet. Microbiol. https:\/\/doi.org\/10.1016\/j.vetmic.2018.04.026 (2018).","journal-title":"Vet. Microbiol."},{"key":"30674_CR8","doi-asserted-by":"publisher","unstructured":"Krentz, D., Bergmann, M., Felten, S., & Hartmann, K. Options for treatment of feline infectious peritonitis\u2014Previously and today. Tier\u00e4rztliche Praxis Ausgabe K: Kleintiere\/Heimtiere. https:\/\/doi.org\/10.1055\/a-2147-3999 (2023)","DOI":"10.1055\/a-2147-3999"},{"issue":"11","key":"30674_CR9","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3390\/v13112228","volume":"13","author":"D Krentz","year":"2021","unstructured":"Krentz, D. et al. Curing cats with feline infectious peritonitis with an oral multi-component drug containing GS-441524. Viruses 13(11), 2228. https:\/\/doi.org\/10.3390\/v13112228 (2021).","journal-title":"Viruses"},{"key":"30674_CR10","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00316","author":"VC Yan","year":"2020","unstructured":"Yan, V. C. & Muller, F. L. Advantages of the parent nucleoside GS-441524 over remdesivir for COVID-19 treatment. ACS Med. Chem. Lett. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00316 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"30674_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/v15081680","author":"E Cosaro","year":"2023","unstructured":"Cosaro, E. et al. Efficacy of oral remdesivir compared to GS-441524 for treatment of cats with naturally occurring effusive feline infectious peritonitis: A blinded, non-inferiority study. Viruses https:\/\/doi.org\/10.3390\/v15081680 (2023).","journal-title":"Viruses"},{"key":"30674_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X231194460","author":"SS Taylor","year":"2023","unstructured":"Taylor, S. S. et al. Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020\u20132022). J. Feline Med. Surg. https:\/\/doi.org\/10.1177\/1098612X231194460 (2023).","journal-title":"J. Feline Med. Surg."},{"key":"30674_CR13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/jvim.15780","volume":"34","author":"PJ Dickinson","year":"2020","unstructured":"Dickinson, P. J. et al. Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis. J. Vet. Intern. Med. 34, 1587\u20131593. https:\/\/doi.org\/10.1111\/jvim.15780 (2020).","journal-title":"J. Vet. Intern. Med."},{"issue":"7","key":"30674_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/v16071144","volume":"16","author":"AM Zuzzi-Krebitz","year":"2024","unstructured":"Zuzzi-Krebitz, A. M. et al. Short treatment of 42 days with oral GS-441524 results in equal efficacy as the recommended 84-day treatment in cats suffering from feline infectious peritonitis with effusion: A prospective randomized controlled study. Viruses 16(7), 1144. https:\/\/doi.org\/10.3390\/v16071144 (2024).","journal-title":"Viruses"},{"key":"30674_CR15","doi-asserted-by":"publisher","first-page":"809480","DOI":"10.4061\/2010\/809480","volume":"2010","author":"S Sharif","year":"2010","unstructured":"Sharif, S. et al. Diagnostic methods for feline coronavirus: A review. Vet. Med. Int. 2010, 809480. https:\/\/doi.org\/10.4061\/2010\/809480 (2010).","journal-title":"Vet. Med. Int."},{"issue":"2","key":"30674_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","volume":"201","author":"NC Pedersen","year":"2014","unstructured":"Pedersen, N. C. An update on feline infectious peritonitis: Diagnostics and therapeutics. Vet. J. 201(2), 133\u2013141. https:\/\/doi.org\/10.1016\/j.tvjl.2014.04.016 (2014).","journal-title":"Vet. J."},{"issue":"8","key":"30674_CR17","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/ani11082257","volume":"11","author":"S Jones","year":"2021","unstructured":"Jones, S., Novicoff, W., Nadeau, J. & Evans, S. Unlicensed GS-441524-like antiviral therapy can be effective for at-home treatment of feline infectious peritonitis. Animals (Basel) 11(8), 2257. https:\/\/doi.org\/10.3390\/ani11082257 (2021).","journal-title":"Animals (Basel)"},{"key":"30674_CR18","unstructured":"Pedersen, N. C. Neurological and Ocular FIP. UC Davis, Center for Companion Animal Health. Updated February 10, 2023. https:\/\/www.sockfip.org\/neurological-and-ocular-fip\/ (2023)"},{"key":"30674_CR19","unstructured":"Pedersen, N. C. Summary of GS-441524 Treatment for FIP. Center for Companion Animal Health, School of Veterinary Medicine, UC Davis. https:\/\/www.sockfip.org\/summary-of-gs-441524-treatment-for-fip\/"},{"key":"30674_CR20","unstructured":"World Small Animal Veterinary Association. Cat Body Condition Scoring 2017. WSAVA, 2017. Accessed April 24, 2025. https:\/\/wsava.org\/wp-content\/uploads\/2020\/01\/Cat-Body-Condition-Scoring-2017.pdf (2025)"},{"key":"30674_CR21","doi-asserted-by":"publisher","unstructured":"Ansari Mood, M. Ophthalmic manifestation in FIP cats and their changes during treatment with GS-441524. Vet. Ophthalmol. 27(Supplement 1), 02\u201316,134. https:\/\/doi.org\/10.1111\/vop.13245 (2024)","DOI":"10.1111\/vop.13245"},{"issue":"12","key":"30674_CR22","doi-asserted-by":"publisher","first-page":"1098612X2312160","DOI":"10.1177\/1098612X231216000","volume":"25","author":"TR M\u00fcller","year":"2023","unstructured":"M\u00fcller, T. R., Penninck, D. G., Webster, C. R. & Conrado, F. O. Abdominal ultrasonographic findings of cats with feline infectious peritonitis: An update. J. Feline Med. Surg. 25(12), 1098612X231216000. https:\/\/doi.org\/10.1177\/1098612X231216000 (2023).","journal-title":"J. Feline Med. Surg."},{"issue":"4","key":"30674_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/1098612X15586209","volume":"18","author":"F Riemer","year":"2016","unstructured":"Riemer, F. et al. Clinical and laboratory features of cats with feline infectious peritonitis: A retrospective study of 231 confirmed cases (2000\u20132010). J. Feline Med. Surg. 18(4), 348\u2013356. https:\/\/doi.org\/10.1177\/1098612X15586209 (2016).","journal-title":"J. Feline Med. Surg."},{"issue":"7","key":"30674_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2460\/javma.2001.218.1111","volume":"218","author":"BW Rohrbach","year":"2001","unstructured":"Rohrbach, B. W. et al. Epidemiology of feline infectious peritonitis among cats examined at veterinary medical teaching hospitals. J. Am. Vet. Med. Assoc. 218(7), 1111\u20131115. https:\/\/doi.org\/10.2460\/javma.2001.218.1111 (2001).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"30674_CR25","unstructured":"Roman, N. Feline Infectious Peritonitis. College Station Cat Clinic, January 2024. Updated September 2024. https:\/\/www.msdvetmanual.com\/infectious-diseases\/feline-infectious-peritonitis\/feline-infectious-peritonitis (2024)"},{"key":"30674_CR26","first-page":"1007","volume":"19","author":"C McReynolds","year":"1997","unstructured":"McReynolds, C. & Macy, D. M. Feline infectious peritonitis. Part I. Etiology and diagnosis. Compend. Contin. Educ. Pract. Vet. 19, 1007\u20131016 (1997).","journal-title":"Compend. Contin. Educ. Pract. Vet."},{"key":"30674_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cvsm.2004.10.011","volume":"35","author":"K Hartmann","year":"2005","unstructured":"Hartmann, K. Feline infectious peritonitis. Vet. Clin. North Am.: Small Anim. Pract. 35, 39\u201379 (2005).","journal-title":"Vet. Clin. North Am.: Small Anim. Pract."},{"key":"30674_CR28","doi-asserted-by":"crossref","unstructured":"Yin, Y., Li, T., Wang, C., et al. A retrospective study of clinical and laboratory features and treatment on cats highly suspected of feline infectious peritonitis in Wuhan, China. Sci. Rep. 11. (2021)","DOI":"10.1038\/s41598-021-84754-0"},{"issue":"1","key":"30674_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jfms.2005.04.003","volume":"8","author":"LD Pesteanu-Somogyi","year":"2006","unstructured":"Pesteanu-Somogyi, L. D., Radzai, C. & Pressler, B. M. Prevalence of feline infectious peritonitis in specific cat breeds. J. Feline Med. Surg. 8(1), 1\u20135. https:\/\/doi.org\/10.1016\/j.jfms.2005.04.003 (2006).","journal-title":"J. Feline Med. Surg."},{"issue":"10","key":"30674_CR30","first-page":"E1","volume":"31","author":"T Goodson","year":"2009","unstructured":"Goodson, T., Randell, S. & Moore, L. Feline infectious peritonitis. Compend. Contin. Educ. Pract. Vet. 31(10), E1\u2013E8 (2009).","journal-title":"Compend. Contin. Educ. Pract. Vet."},{"issue":"9","key":"30674_CR31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2460\/javma.1997.210.09.1313","volume":"210","author":"JE Foley","year":"1997","unstructured":"Foley, J. E., Poland, A., Carlson, J. & Pedersen, N. C. Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus. J. Am. Vet. Med. Assoc. 210(9), 1313\u20131318 (1997).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"30674_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jfms.2003.08.008","volume":"6","author":"NC Pedersen","year":"2004","unstructured":"Pedersen, N. C., Sato, R., Foley, J. E. & Poland, A. M. Common virus infections in cats, before and after being placed in shelters, with emphasis on feline enteric coronavirus. J. Feline Med. Surg. 6, 83\u201388 (2004).","journal-title":"J. Feline Med. Surg."},{"key":"30674_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1051\/vetres\/2010043","volume":"41","author":"L Vogel","year":"2010","unstructured":"Vogel, L. et al. pathogenic characteristics of persistent feline enteric coronavirus infection in cats. Vet. Res. 41, 71 (2010).","journal-title":"Vet. Res."},{"key":"30674_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jfms.2008.02.006","volume":"10","author":"NC Pedersen","year":"2008","unstructured":"Pedersen, N. C., Allen, C. E. & Lyons, L. A. Pathogenesis of feline enteric coronavirus infection. J. Feline Med. Surg. 10, 529\u2013541 (2008).","journal-title":"J. Feline Med. Surg."},{"key":"30674_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jfms.2008.09.008","volume":"11","author":"NC Pedersen","year":"2009","unstructured":"Pedersen, N. C. A review of feline infectious peritonitis virus infection: 1963\u20132008. J. Feline Med. Surg. 11, 225\u2013258 (2009).","journal-title":"J. Feline Med. Surg."},{"issue":"4","key":"30674_CR36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.14202\/vetworld.2023.820-827","volume":"16","author":"W Moyadee","year":"2023","unstructured":"Moyadee, W. et al. The first study on clinicopathological changes in cats with feline infectious peritonitis with and without retrovirus coinfection. Vet. World 16(4), 820\u2013827. https:\/\/doi.org\/10.14202\/vetworld.2023.820-827 (2023).","journal-title":"Vet. World"},{"issue":"2","key":"30674_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.30574\/gscbps.2019.6.2.0011","volume":"6","author":"H Aydin","year":"2019","unstructured":"Aydin, H. & Yildirim, S. Investigation of the relation between feline infectious peritonitis and retroviruses in cats. GSC Biol. Pharmaceut. Sci. 6(2), 71\u201378. https:\/\/doi.org\/10.30574\/gscbps.2019.6.2.0011 (2019).","journal-title":"GSC Biol. Pharmaceut. Sci."},{"issue":"1","key":"30674_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00705-008-0265-9","volume":"154","author":"T Takano","year":"2009","unstructured":"Takano, T., Azuma, N., Hashida, Y., Satoh, R. & Hohdatsu, T. B-cell activation in cats with feline infectious peritonitis (FIP) by FIP-virus-induced B-cell differentiation\/survival factors. Adv. Virol. 154(1), 27\u201335. https:\/\/doi.org\/10.1007\/s00705-008-0265-9 (2009).","journal-title":"Adv. Virol."},{"issue":"2","key":"30674_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jfms.2010.09.014","volume":"13","author":"HY Tsai","year":"2011","unstructured":"Tsai, H. Y., Chueh, L. L., Lin, C. N. & Su, B. L. Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan. J. Feline Med. Surg. 13(2), 74\u201380. https:\/\/doi.org\/10.1016\/j.jfms.2010.09.014 (2011).","journal-title":"J. Feline Med. Surg."},{"issue":"11","key":"30674_CR40","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/v11111068","volume":"11","author":"S Felten","year":"2019","unstructured":"Felten, S. & Hartmann, K. Diagnosis of feline infectious peritonitis: A review of the current literature. Viruses 11(11), 1068. https:\/\/doi.org\/10.3390\/v11111068 (2019).","journal-title":"Viruses"},{"key":"30674_CR41","unstructured":"Fonte-Oliveira, L., Lopes, C., Malh\u00e3o, F., et al. The utility of the cell tube block technique in the diagnosis of effusive feline infectious peritonitis. In Proceedings of the Congress of European Society of Veterinary Clinical Pathology (ESVCP\/ECVCP), vol: 148. (University of Veterinary Medicine, Budapest, Hungary, 2024)"},{"key":"30674_CR42","doi-asserted-by":"crossref","unstructured":"Katayama, M., & Uemura, Y. Therapeutic effects of Mutian\u00ae Xraphconn on 141 client-owned cats with feline infectious peritonitis predicted by total bilirubin levels. Vet. Sci. (2021).","DOI":"10.3390\/vetsci8120328"},{"key":"30674_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jfms.2007.06.004","volume":"10","author":"D Timmann","year":"2008","unstructured":"Timmann, D. et al. Retrospective analysis of seizures associated with feline infectious peritonitis in cats. J. Feline Med. Surg. 10, 9\u201315. https:\/\/doi.org\/10.1016\/j.jfms.2007.06.004 (2008).","journal-title":"J. Feline Med. Surg."},{"key":"30674_CR44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jfms.2009.05.008","volume":"11","author":"D Addie","year":"2009","unstructured":"Addie, D. et al. Feline infectious peritonitis: ABCD guidelines on prevention and management. J. Feline Med. Surg. 11, 594\u2013604. https:\/\/doi.org\/10.1016\/j.jfms.2009.05.008 (2009).","journal-title":"J. Feline Med. Surg."},{"key":"30674_CR45","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.cvsm.2011.08.004","volume":"41","author":"Y Drechsler","year":"2011","unstructured":"Drechsler, Y., Alcaraz, A., Bossong, F. J., Collisson, E. W. & Diniz, P. P. Feline coronavirus in multicat environments. Vet. Clin. North Am.: Small Anim. Pract. 41, 1133\u20131160 (2011).","journal-title":"Vet. Clin. North Am.: Small Anim. Pract."},{"issue":"10","key":"30674_CR46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/pathogens9100824","volume":"9","author":"AJ Malbon","year":"2020","unstructured":"Malbon, A. J. et al. The effect of natural feline coronavirus infection on the host immune response: A whole-transcriptome analysis of the mesenteric lymph nodes in cats with and without feline infectious peritonitis. Pathogens 9(10), 824. https:\/\/doi.org\/10.3390\/pathogens9100824 (2020).","journal-title":"Pathogens"},{"issue":"2\u20133","key":"30674_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1053\/jcpa.2001.0501","volume":"125","author":"A Kipar","year":"2001","unstructured":"Kipar, A. & Meli, M. L. A comparison of lymphatic tissues from cats with spontaneous feline infectious peritonitis (FIP), cats with FIP virus infection but no FIP, and cats with no infection. J. Comp. Pathol. 125(2\u20133), 182\u2013191. https:\/\/doi.org\/10.1053\/jcpa.2001.0501 (2001).","journal-title":"J. Comp. Pathol."},{"key":"30674_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5326\/0460152","volume":"46","author":"KM Lewis","year":"2010","unstructured":"Lewis, K. M. & O\u2019Brien, R. T. Abdominal ultrasonographic findings associated with feline infectious peritonitis: A retrospective review of 16 cases. J. Am. Anim. Hosp. Assoc. 46, 152\u2013160. https:\/\/doi.org\/10.5326\/0460152 (2010).","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"30674_CR49","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1476-4431.2009.00474.x","volume":"19","author":"JE Quantz","year":"2009","unstructured":"Quantz, J. E., Miles, M. S., Reed, A. L. & White, G. A. Elevation of alanine transaminase and gallbladder wall abnormalities as biomarkers of anaphylaxis in canine hypersensitivity patients. J. Vet. Emerg. Critic. Care (San Antonio) 19, 536\u2013544. https:\/\/doi.org\/10.1111\/j.1476-4431.2009.00474.x (2009).","journal-title":"J. Vet. Emerg. Critic. Care (San Antonio)"},{"key":"30674_CR50","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2460\/javma.251.6.681","volume":"251","author":"AM Walters","year":"2017","unstructured":"Walters, A. M., O\u2019Brien, M. A., Selmic, L. E. & McMichael, M. A. Comparison of clinical findings between dogs with suspected anaphylaxis and dogs with confirmed sepsis. J. Am. Vet. Med. Assoc. 251, 681\u2013688. https:\/\/doi.org\/10.2460\/javma.251.6.681 (2017).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"30674_CR51","unstructured":"Mattoon, J. S., & Nyland, T. G. Handbook of small animal radiology and sonography. 2nd ed. (Saunders, Elsevier, 2010)."},{"issue":"1","key":"30674_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36483\/vanvetj.1232729","volume":"34","author":"E G\u00fclersoy","year":"2023","unstructured":"G\u00fclersoy, E., Y\u0131lmaz, Z., \u00c7etinkaya, M. A. & Vural, S. A. Renal ultrasonography findings in cats with feline infectious peritonitis. Van Vet. J. 34(1), 1\u20136. https:\/\/doi.org\/10.36483\/vanvetj.1232729 (2023).","journal-title":"Van Vet. J."},{"issue":"5","key":"30674_CR53","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1111\/jvim.15878","volume":"34","author":"A Cordella","year":"2020","unstructured":"Cordella, A. et al. The ultrasonographic medullary \u2018Rim Sign\u2019 versus medullary \u2018band sign\u2019 in cats and their association with renal disease. J. Vet. Intern. Med. 34(5), 1932\u20131939. https:\/\/doi.org\/10.1111\/jvim.15878 (2020).","journal-title":"J. Vet. Intern. Med."},{"key":"30674_CR54","doi-asserted-by":"publisher","unstructured":"Pressler, B. M. Renomegaly: Workup and management of select cases. (The Ohio State University, College of Veterinary Medicine). https:\/\/doi.org\/10.5555\/20123241239.","DOI":"10.5555\/20123241239"},{"issue":"1","key":"30674_CR55","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jvim.16954","volume":"38","author":"M Allinder","year":"2023","unstructured":"Allinder, M. et al. Uroliths composed of antiviral compound GS-441524 in 2 cats undergoing treatment for feline infectious peritonitis. J. Vet. Intern. Med. 38(1), 370\u2013374. https:\/\/doi.org\/10.1111\/jvim.16954 (2023).","journal-title":"J. Vet. Intern. Med."},{"issue":"2","key":"30674_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ckj\/sfu008","volume":"7","author":"H Izzedine","year":"2014","unstructured":"Izzedine, H., Lescure, F. X. & Bonnet, F. HIV medication-based urolithiasis. Clin. Kidney J. 7(2), 121\u2013126. https:\/\/doi.org\/10.1093\/ckj\/sfu008 (2014).","journal-title":"Clin. Kidney J."},{"issue":"suppl. 1A","key":"30674_CR57","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0002-9343(82)90088-2","volume":"73","author":"MR Blum","year":"1982","unstructured":"Blum, M. R., Liao, S. H. T. & de Miranda, P. Overview of acyclovir pharmacokinetics disposition in adults and children. Am. J. Med. 73(suppl. 1A), 186\u2013192 (1982).","journal-title":"Am. J. Med."},{"key":"30674_CR58","first-page":"25","volume":"20","author":"SG Trulove","year":"1992","unstructured":"Trulove, S. G., McCahon, H. A., Nichols, R. & Fooshee, S. K. Pyogranulomatous pneumonia associated with generalized noneffusive feline infectious peritonitis. Feline Pract. 20, 25\u201329 (1992).","journal-title":"Feline Pract."},{"key":"30674_CR59","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1098612X17729626","volume":"20","author":"NC Pedersen","year":"2018","unstructured":"Pedersen, N. C. et al. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J. Feline Med. Surg. 20, 378\u2013392 (2018).","journal-title":"J. Feline Med. Surg."},{"key":"30674_CR60","doi-asserted-by":"publisher","first-page":"1422408","DOI":"10.3389\/fvets.2024.1422408","volume":"11","author":"O Sase","year":"2024","unstructured":"Sase, O., Iwami, T., Sasaki, T. & Sano, T. GS-441524 and Molnupiravir are similarly effective for the treatment of cats with feline infectious peritonitis. Front. Vet. Sci. 11, 1422408. https:\/\/doi.org\/10.3389\/fvets.2024.1422408 (2024).","journal-title":"Front. Vet. Sci."},{"key":"30674_CR61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1126\/science.3871252","volume":"227","author":"CJ Grossman","year":"1985","unstructured":"Grossman, C. J. Interactions between the gonadal steroids and the immune system. Science 227, 257\u2013261 (1985).","journal-title":"Science"},{"key":"30674_CR62","doi-asserted-by":"publisher","unstructured":"Goto, S., Kamiyoshi, T., Iwasaki, R. Predictive factors associated with short-term mortality in cats with feline infectious peritonitis treated with remdesivir or GS-441524 or Both. J. Vet. Internal Med. https:\/\/doi.org\/10.1111\/jvim.17249 (2024)","DOI":"10.1111\/jvim.17249"},{"key":"30674_CR63","unstructured":"Hartmann, K., Binder, C., Hirschberger, J., et al. Predictive values of different tests in the diagnosis of feline infectious peritonitis. Abstract. In Abstracts of the Second International Feline Coronavirus\/Feline Infectious Peritonitis Symposium. (Glasgow, Scotland, 2002)."},{"key":"30674_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0021-9975(98)80071-6","volume":"119","author":"W Breuer","year":"1998","unstructured":"Breuer, W., Stahr, K. & Majzoub, M. Bone-marrow changes in infectious diseases and lymphohaemopoietic neoplasias in dogs and cats\u2014A retrospective study. J. Comp. Pathol. 119, 57\u201366 (1998).","journal-title":"J. Comp. Pathol."},{"key":"30674_CR65","doi-asserted-by":"publisher","DOI":"10.12968\/coan.2022.0016","author":"S Sorrell","year":"2022","unstructured":"Sorrell, S., Pugalendhi, S. J. & Gunn-Moore, D. Current treatment options for feline infectious peritonitis in the UK. Companion Anim. https:\/\/doi.org\/10.12968\/coan.2022.0016 (2022).","journal-title":"Companion Anim."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30674-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:29:15Z","timestamp":1767882555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30674-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30674-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures in this study were carried out as part of routine clinical veterinary care. Informed consent was obtained in writing from all pet owners prior to the initiation of treatment. Owners were fully informed that GS-441524 is not FDA-approved for use in cats and that the treatment protocol was based on published research by Dr. Niels Pedersen. The Iranian Society for the Prevention of Cruelty to Animals (IRSPCA) formally permitted the administration of this treatment protocol. All methods were performed in accordance with relevant veterinary clinical guidelines and ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"1037"}}